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Intercellular communication is an essential
bedrock in the maintenance and develop-
ment of multicellular organisms.
Conventional models of cellular
exchange include transfer of secreted mol-
ecules and direct contact; only recently,
exosomes have emerged as a new avenue
for cell-to-cell communication.
Discovered nearly 30 years ago, exo-
somes were initially considered little cel-
lular garbage disposals acting to discard
unwanted proteins and molecules, and
research on exosome biology developed at
an extremely slow pace; it is only in the past
two decades or so that we have been able to
unscramble some of the various biological
roles of these nanovesicles.
The foundation for the hypothesis that
exosomes could play a large and active
role in intercellular communication came
in 1996, when Graca Raposo published her
discovery of exosomes, secreted by Epstein-
Barr virus transformed B lymphocytes, able
to induce antigen-specific MHC class II-
restricted T cell responses (1). Interest in
exosomes was boosted further by a publi-
cation in 1998 by Zitvogel’s team report-
ing that dendritic cell-derived exosomes
could promote the induction of antitu-
mor response in mice, prompting the first
attempt for their clinical application (2).
Over the past few years, however, consid-
erable research really brings us closer to
harnessing the potential of these tiny vesi-
cles as both a diagnostic and therapeutic
tool.
Secreted by multiple cell types and vir-
tually found in all body fluids, exosomes
are nano-sized, cell membrane surrounded
structures harboring a broad range of
biomolecules, including mRNAs, miRNAs,
and proteins linked to cell type-associated
functions. To understand the biological
function of exosomes, a number of pro-
teomic and transcriptomic profile studies
has been performed. The huge amount of
data obtained have allowed researchers to
develop Exocarta.com, a free web-based
and centralized repository of molecules
that have been documented in exosomes, in
order to facilitate novel biological insight.
Exosomes were subsequently found to play
important role in influencing physiological
pathways in the recipient cells (3).
In this scenario, studies on MC-derived
exosomes represented a fundamental start-
ing point for the definition of their biolog-
ical functions.
MCs have been slowly but definitely
shed out their image of allergy-causing
troublemakers and have emerged as ver-
satile cells with the ability to orchestrate
several biological processes. Even though
MCs are traditionally considered a secre-
tory cell type, it is possible to ascribe their
phenotypic and functional plasticity not
only to their capacity to respond to a wide
range of signals with the production of dis-
tinct patterns of mediators, but also to their
ability in establishing direct intercellular
interactions (4). Nevertheless, in addition
to these traditional mechanisms for cell-
to-cell communication, exosomes may also
empower MCs to interact with different
targets.
In 2001, Skokos described for the first
time, the ability of bone marrow MCs,
peritoneal MCs, and MC lines P815 and
MC/9 to constitutively secrete exosomes.
More importantly, he provided that MCs
use exosomes as sophisticated messengers
showing immunoregulatory activity on B
and T lymphocytes (5).
Six years later, the remarkable discov-
ery by the group of Lötvall has provided
a major breakthrough in exosome research
opening up new avenues regarding diag-
nosis and therapeutics. They demonstrated
that exosomes from human MCs carry
a distinct repertoire of both mRNA and
microRNA, also documenting the ability of
MCs to shuttle RNA between each other via
exosomes (6).
Since then, few evidence indicates that
MC-derived exosomes play a pivotal role
in cell-to-cell communication. The func-
tional consequences of such vesicle trans-
fers include the induction, amplification,
and/or modulation of immune responses,
epigenetic reprograming as well as the
acquisition of new functional properties by
recipient cells (tumor cells, muscle cells,
and endothelial cells). Owing to the lim-
ited progress in the field, the pathophys-
iological relevance of exosomes released
by MCs have been unaddressed. However,
the strategic and ubiquitous tissue distri-
bution of these cells and their ability to
release different types of nanovesicles may
provide them with an unique opportunity
for harnessing and improving exosomes’
therapeutic and diagnostic capabilities.
With Lötvall’s discovery and the con-
comitant explosion of studies on microR-
NAs, the importance of exosomes has
extended beyond their natural function
and attempts to find practical applica-
tion for exosomes are currently expanding.
Therapeutically, exosomes may represent
an efficient vehicle for drug or gene deliv-
ery with fewer potential hazards from a
safety standpoint, because of their excellent
host biodistribution and biocompatibility
as well as their natural targeting properties.
Moreover, exosomes are garnering
attention in diagnostics as cost-effective
and efficient biomarkers. Since they can be
found in most body fluids, exosomes can
be collected in an easily and non-invasive
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way, making possible the real-time tracking
of a patient’s disease progression (7).
As documented in clinicaltrial.gov, exo-
somes have already been approved for their
use in clinical trials for different target
patients. However, clinical translation is
limited by the lack of scalable and econom-
ically viable methods for generation and
loading of exosomes.
Undoubtedly, exosome-based therapy
and diagnostics offer an exceptional alter-
native for diseases treatment in the future.
Technological improvement of standard-
ized purification method, a systematic
characterization, an overall engineeriza-
tion approach will help us to improve their
utilization as diagnostic markers and fur-
ther develop exosome-based translational
nanomedicine.
The field of exosomics is as such still in
its infancy, and consequently much basic
research and integrative studies remain to
be done. Certainly, a significant amount
of work still lies ahead before the com-
position, function, and potential of these
intriguing vesicles have been unrevealed.
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